What is Talyst?
Talyst specializes in offering comprehensive medication management and pharmacy software solutions, including program auditing and medical equipment services. Its flagship enterprise solution, AutoPharm Enterprise, is designed to streamline inventory management across health systems. The company primarily serves acute care hospitals and integrated healthcare companies within the United States, providing critical automation solutions to enhance operational efficiency and patient care. Founded in 2002 and based in Washington, Talyst has established itself as a key player in the healthcare IT landscape.
How much funding has Talyst raised?
Talyst has raised a total of $36M across 3 funding rounds:
Unspecified
$20M
Private Equity
$6M
Unspecified
$10M
Unspecified (2006): $20M with participation from OVP Venture Partners and Ignition Partners
Private Equity (2009): $6M, investors not publicly disclosed
Unspecified (2012): $10M supported by ORIX USA
Key Investors in Talyst
ORIX USA
ORIX USA is a global financial services organization providing a wide range of investment, financing, and asset management solutions. They operate as a diversified financial platform supporting organizations in managing capital and pursuing strategic growth opportunities.
OVP Venture Partners
OVP Venture Partners focuses on early-stage investments in cleantech, digital biology, and information technology, with a strong track record in the Pacific Northwest technology market.
What's next for Talyst?
The recent major strategic investment signals a new phase of growth for Talyst, likely enabling further development of its software platforms and expansion into new markets. This capital infusion is expected to bolster its competitive edge in the enterprise-level healthcare software domain. Future initiatives may include enhancing AI capabilities for predictive analytics in medication management, expanding its service offerings to a broader range of healthcare providers, and potentially exploring strategic partnerships to broaden its reach. The company's trajectory suggests a focus on solidifying its market leadership and driving innovation in pharmacy automation.
See full Talyst company page
